SICK AG vs. Vision Augmentation Technology: Swift Dismissal in Stereoscopic Imaging Patent Case
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | SICK AG vs. Vision Augmentation Technology LLC |
| Case Number | 0:25-cv-04155 (D. Minn.) |
| Court | U.S. District Court for the District of Minnesota |
| Duration | Oct 2025 – Jan 2026 88 days |
| Outcome | Dismissal with Prejudice |
| Patents at Issue |
Case Overview
The Parties
⚖️ Plaintiff
Globally recognized German manufacturer of sensors, safety systems, and industrial automation technology with a robust IP portfolio spanning optical sensing, machine vision, and imaging technologies.
🛡️ Defendant
Based on its name and the nature of the patent asserted, the entity appears structured as a patent assertion entity (PAE) or specialized IP holding company focused on augmented vision technology.
The Patent at Issue
This case centered on U.S. Patent No. 7,433,021 B2, covering a “Stereoscopic Targeting, Tracking and Navigation Device, System and Method.” This patent addresses technology enabling stereoscopic — or three-dimensional depth-sensing — systems to track, target, and navigate objects within a scene.
- • US 7,433,021 B2 — Stereoscopic Targeting, Tracking and Navigation Device, System and Method
Developing 3D vision systems?
Check if your technology might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
SICK AG voluntarily dismissed Case No. 0:25-cv-04155 **with prejudice** pursuant to FRCP 41(a)(1)(A)(i) on January 26, 2026. This dismissal was self-executing and filed before Vision Augmentation Technology LLC served an answer or summary judgment motion. No damages were awarded, and no injunctive relief was granted or denied. The “with prejudice” designation bars SICK AG from refiling the same claims against this defendant in any future action.
Key Legal Issues
The case was initiated as a standard patent infringement action, resolving in the pre-answer phase. The use of FRCP 41(a)(1)(A)(i) means a plaintiff may dismiss as of right without prejudice or with prejudice — the latter being a more permanent election. SICK AG’s choice to dismiss with prejudice, absent any disclosed settlement terms, invites interpretations of either a confidential settlement or a strategic reassessment by the plaintiff regarding claim construction risks, prior art exposure, or enforcement economics.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in stereoscopic imaging. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this technology space
- See which companies are most active in 3D vision patents
- Understand claim construction patterns for stereoscopic systems
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Stereoscopic targeting and tracking systems
Active Patent
US 7,433,021 B2
Design-Around Options
Available for many technical claims
✅ Key Takeaways
FRCP 41(a)(1)(A)(i) dismissals with prejudice are powerful tools for locking in negotiated resolutions without court involvement or public disclosure of terms.
Search related case law →Pre-answer resolution timelines (under 90 days) are increasingly common in patent cases where experienced counsel on both sides assess risks early and efficiently.
Explore precedents →Frequently Asked Questions
The case centered on U.S. Patent No. 7,433,021 B2 (Application No. 11/161,044), covering a “Stereoscopic Targeting, Tracking and Navigation Device, System and Method.”
SICK AG voluntarily dismissed under FRCP 41(a)(1)(A)(i) before the defendant filed an answer or summary judgment motion. The “with prejudice” designation prevents re-filing of the same claims, suggesting a negotiated resolution was likely reached privately.
It signals continued enforcement activity around 3D vision and targeting patents. Companies in this technology space should prioritize FTO analysis and monitor related patent portfolios for additional assertion risk.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- United States Patent and Trademark Office – US Patent No. 7,433,021 B2
- Federal Rule of Civil Procedure 41(a)(1)(A)(i)
- U.S. District Court for the District of Minnesota – Case No. 0:25-cv-04155
- PatSnap — IP Intelligence Solutions for Industrial Automation
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.